Dr. Anna M. Becker is a clinical psychologist and is currently completing her training as a psychotherapist. She completed her doctorate in the psychopharmacology research group headed by Prof. Matthias Liechti. In this work, she has accompanied over 200 psychedelic sessions with healthy test subjects and patients, and her research interests lie primarily in the area of the risks and side effects of psychedelics and MDMA.

Background:

Studied psychology and neuroscience at the University of Basel 2019

Further training as a federal psychotherapist (Swiss Society for the Person-Centered Approach to Psychotherapy, Zurich) since 2022.

PhD clinical research on interaction of selective serotonin reuptake inhibitors, a serotonin-2A antagonist and psychedelics at the University of Basel 2025.

Clinical work at the University Psychiatric Clinics Basel (UPK) in the Center for Addictive Disorders since 2025.